Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional genomics and the breast cancer problem.

Tan A Ince1, Robert A Weinberg

  • 1Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Cancer Cell
|June 28, 2002
PubMed
Summary

Accurately predicting breast cancer metastasis is challenging. Functional genomics identified gene markers that predict patient relapse or tumor-free status five years post-treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intrinsic and extrinsic regulators of cancer dormancy and awakening.

Journal of the National Cancer Center·2026
Same author

Editorial Expression of Concern: Creation of human tumour cells with defined genetic elements.

Nature·2026
Same author

A Metal-Free Carbon Monoxide Prodrug Suppresses Metastasis of Pancreatic and Breast Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Ether lipids influence cancer cell fate by modulating iron uptake.

Nature communications·2026
Same author

Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer.

EMBO molecular medicine·2025

Area of Science:

  • Oncology
  • Genomics
  • Translational Medicine

Background:

  • Clinical treatment of primary breast cancers is complicated by the inability to predict tumor behavior (metastatic vs. localized).
  • Current practices often lead to overtreatment of patients with indolent tumors due to lack of predictive markers.
  • Accurate prediction of tumor invasiveness and metastatic potential is crucial for personalized treatment strategies.

Purpose of the Study:

  • To identify reliable gene expression markers for predicting clinical outcomes in primary breast cancer patients.
  • To differentiate between patients likely to relapse and those likely to remain tumor-free after initial treatment.

Main Methods:

  • Utilized functional genomics analysis to identify a set of gene markers.
  • Correlated gene expression patterns with patient outcomes (relapse vs. tumor-free status) at the five-year mark.

Main Results:

  • Successfully assembled a panel of gene markers based on functional genomics.
  • Demonstrated that the expression levels of these markers can predict, with reasonably high accuracy, whether a patient will relapse or remain tumor-free five years after diagnosis and treatment.

Conclusions:

  • Functional genomics offers a powerful approach to developing predictive biomarkers for breast cancer.
  • The identified gene markers can potentially guide treatment decisions, avoiding unnecessary aggressive therapy for indolent tumors and ensuring timely intervention for high-risk patients.

Related Experiment Videos